- Diseases - human ×
-
JMM Editor's Choice: Mutations causing antimicrobial resistance in Helicobacter pylori
April 3, 2019
The Journal of Medical Microbiology (JMM) is a journal published by the Microbiology Society, focused on providing a comprehensive coverage of medical, dental and veterinary microbiology and infectious diseases, including bacteriology, virology, mycology and parasitology. This month, Dr Arunaloke Chakrabarti, has selected an outstanding paper from the April issue to highlight as Editor’s Choice. The paper, titled 'Comparison of new and classical point mutations associated with clarithromycin resistance in Helicobacter pylori strains isolated from dyspeptic patients and their effects on phenotypic clarithromycin resistance' discusses the factors contributing to resistance in H. pylori.
-
Microbe Talk: Cryptococcus neoformans – The Pigeon Fungus
March 29, 2019
On this month’s podcast, we discuss the fungus Cryptococcus neoformans with Dr Liz Ballou from the University of Birmingham.
-
World TB Day: A Q&A with Professor Tanya Parish
March 22, 2019
Sunday 24 March marks World Tuberculosis Day. On this day in 1882, Robert Koch announced he had discovered the causative agent of tuberculosis (TB), which was a major development in understanding the disease and working towards finding treatment options. In this post, we discuss TB research with Professor Tanya Parrish, Editor-in-Chief of the Society's flagship journal, Microbiology, and Head of the TB Discovery Research Group at the Infectious Disease Research Institute (IDRI) in the US.
-
JMM Editor's Choice: drivers of persistent Pseudomonas infection in cystic fibrosis
March 18, 2019
The Journal of Medical Microbiology (JMM) is a journal published by the Microbiology Society, focused on providing a comprehensive coverage of medical, dental and veterinary microbiology and infectious diseases, including bacteriology, virology, mycology and parasitology. This month, Professor Vincent Cattoir has selected an outstanding paper from the March issue to highlight as Editor’s Choice. The paper, titled 'Agmatine accumulation by Pseudomonas aeruginosa clinical isolates confers antibiotic tolerance and dampens host inflammation' discusses the role of agmatine, a molecule produced by P. aeruginosa, on antibiotic resistance and the host immune response.
-
New antibiotics needed: Haemophilus influenzae
March 14, 2019
In 2017, the World Health Organization (WHO) published the ’12 Priority Pathogens’: a list of twelve microbes that are becoming increasingly resistant to current antimicrobials. These twelve pathogens are thought by WHO to pose the greatest threat to human health.
-
Could antibiotics be making Campylobacter jejuni more dangerous?
March 4, 2019
The January Junior Awards for Microbiology (JAM) talks took place in Birmingham on the 25 January. PhD student Matthew Whelan was speaking, and in the second of our blogs from speakers at the JAM talks, Matthew takes us through his research into Campylobacter jejuni.
-
New antibiotics needed: Enterobacteriaceae
November 14, 2018
Continuing on our New Antibiotics Needed blog series, today we will be exploring β-lactamase-producing and carbapenemase-producing Enterobacteriaceae.
-
New antibiotics needed: WHO priority pathogens
November 12, 2018
Bacteria are becoming resistant to antimicrobial medicines at an alarming rate. As antibiotics are used to treat infections, bacteria are able to adapt to survive, particularly when antibiotics are used inappropriately, or the full course is not completed.